Zobrazeno 1 - 10
of 25
pro vyhledávání: '"G. M. Portenko"'
Autor:
G. P. Shmatov, G. M. Portenko
Publikováno v:
Russian Otorhinolaryngology. 20:77-85
A mathematical model of the neural network has been used to classify sick women with diagnosed allergic and vasomotor rhinitis in three forms: allergic rhinitis (ARhinitis), vasomotor rhinitis (VRhinitis) and mixed rhinitis (MRhinitis). When checking
Publikováno v:
Russian Otorhinolaryngology. 97:38-47
Publikováno v:
Russian Otorhinolaryngology. 95:78-83
Autor:
G. M. Portenko, G. P. Shmatov
Publikováno v:
Russian Otorhinolaryngology. 16
Using the advanced information technologies, the authors proved one chronic inflammatory diseases of the pharynx in the form of chronic tonsillopharyngitis and chronic pharyngotonsillitis depending on predominant damage of the pharynx elements: palat
Publikováno v:
Russian Otorhinolaryngology. 15
The authors carried out the examination and identification of disbiotic changes of intestinal microflora state as a risk factor for recurrence of polypoid rhinosinusitis. The research has shown the need for correction of disbiotic intestinal microflo
Publikováno v:
Russian Otorhinolaryngology. 15
Publikováno v:
Russian Otorhinolaryngology. 15
Informative significant symptoms of chronic allergic (CAR) and chronic vasomotor (CVR) rhinopathies, revealed by means of the algorithm developed by the authors, and the substantiated diagnostic significance of these symptoms in both of nosologies, s
Autor:
G M, Portenko, N A, Grafskaia
Publikováno v:
Vestnik otorinolaringologii. (5)
The results of treatment of various forms of chronic pharyngitis by magnetolaserophoresis (MLP) with heparin show that MLP is more effective in hypertrophic chronic pharyngitis. It is emphasized that when planning treatment of chronic pharyngitis one
Autor:
G M, Portenko, K V, Dobrynin
Publikováno v:
Vestnik otorinolaringologii. (5)
Transcranial electrostimulation (Transair-2) in patients with polypous rhinosinusitis having initial vagotonic type at optimal therapeutic doses 2.6-2.8 mA potentiates immunocorrective action of leukinferon. This effect was achieved due to impact on
Publikováno v:
Vestnik otorinolaringologii. (4)